Copyright
©The Author(s) 2016.
World J Gastroenterol. May 21, 2016; 22(19): 4638-4650
Published online May 21, 2016. doi: 10.3748/wjg.v22.i19.4638
Published online May 21, 2016. doi: 10.3748/wjg.v22.i19.4638
Figure 3 Immune checkpoints on tumor cell and T-cell, and their monoclonal antibodies evaluated in gastric cancer patients.
CTLA-4: Cytotoxic T-lymphocyte-associated protein 4; PD-1: Programmed cell death-1; PD-L1: Programmed cell death ligand-1.
- Citation: Joo MK, Park JJ, Chun HJ. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management. World J Gastroenterol 2016; 22(19): 4638-4650
- URL: https://www.wjgnet.com/1007-9327/full/v22/i19/4638.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i19.4638